- Biocon says first set of biosimilars to hit European market by early 2018
Two of the biosimilars—trastuzumab and pegfilgrastim—are under review by drug regulator European Medicines Agency. Photo: Hemant Mishra/Mint Hyderabad: Bio-pharmaceutical company […]Lenovo Yoga 730-13 review: Ultra-portable, zippy performance, worthy MacBook Air competitor
Whenever you think of laptops, the usual image of a bulky clamshell device comes alive in mind. Even in 2019, […]Colon cancer: Could proinflammatory diets raise risk?
New research published in the journal JAMA Oncology explores the link between inflammation-inducing diets and the risk of developing colon cancer. The study was […]Derma roller for stretch marks
Stretch marks are a common problem that can occur during pregnancy, weight loss, or muscle strain. While there is no […]